Effect of aspirin, ACE inhibitors/sartans and statins use on the progression of BD-IPMN in follow up: a multicenter study

Objectives Aspirin (ASA), Ace Inibitors/Sartans (ACEI/ARB) and Statins (STAT) inhibit tumoral growth in several clinical and preclinical models, including pancreatic cancer (PDAC). These drugs might, therefore, slow the progression of PDAC precursor lesions, such as IPMNs, but this has been poorly investigated.

Source: Pancreatology - June 1, 2018 Category: Gastroenterology Authors: Roberto Valente, Stefano Crippa, Giuseppe Vanella, Giulia Zerboni, Alessandro Fogliati, Urban Arnelo, Massimo Falconi, Gabriele Capurso, Marco Del Chiaro Tags: 7. Cystic lesions of the pancreas Source Type: research